• [¹⁸F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration
• A - 84 Neuropsychological Phenotypes of FDG-PET Identified Corticobasal Degeneration Pathology
• Accuracy of routinely collected hospital administrative discharge data and death certificate ICD-10 diagnostic coding in progressive supranuclear palsy and corticobasal syndrome: a systematic review and validation study
• Age-Related Pathology in Corticobasal Degeneration
• Aggregation, Transmission, and Toxicity of the Microtubule-Associated Protein Tau: A Complex Comprehension
• Amyloid-β prediction machine learning model using source-based morphometry across neurocognitive disorders
• Anti-alpha synuclein and anti-tau immunotherapies: Can a cocktail approach work?
• Association of Neurofilament Light Chain, [¹⁸F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With β-Amyloid-Negative CBS
• Association of Parkinson's disease to Parkinson's plus syndromes, Lewy body dementia, and Alzheimer's dementia
• Behavioral and histological analyses of the mouse <em>Bassoon</em> p.P3882A mutation corresponding to the human <em>BSN</em> p.P3866A mutation
• Brain perfusion SPECT in dementia: what radiologists should know
• Can multiple system atrophy clinically be misdiagnosed as corticobasal syndrome in the early stages?
• Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer's disease and related dementias
• Chromogranin A (CgA) Deficiency Attenuates Tauopathy by Altering Epinephrine-Alpha-Adrenergic Receptor Signaling
• Chromogranin A Deficiency Attenuates Tauopathy by Altering Epinephrine-Alpha-Adrenergic Receptor Signaling
• Clinical course in corticobasal syndrome and corticobasal degeneration: implications for diagnosis and management
• Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome
• Clinical dimensions along the non-fluent variant primary progressive aphasia spectrum
• Clinicopathologic and Neuroimaging Correlations of Nonverbal Oral Apraxia in Patients With Neurodegenerative Disease
• Clinicoradiological and neuropathological evaluation of primary progressive aphasia
• Combined non-invasive neuromodulation using transcranial direct current stimulation, motor imagery and action observation for motor, cognitive and functional recovery in cortico-basal degeneration: a single case study
• Comparing classic-onset corticobasal syndrome to speech/language-onset corticobasal syndrome
• Conventional magnetic resonance imaging key features for distinguishing pathologically confirmed corticobasal degeneration from its mimics: a retrospective analysis of the J-VAC study
• Correction to: Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome
• Cortico-basal syndrome and cortico-basal degeneration: From the clinical diagnosis to the lesional substrate for an adapted care
• Corticobasal degeneration with visual hallucination as an initial symptom: A case report
• Corticobasal syndrome mimicking Foix-Chavany-Marie syndrome with suggested 4-repeat tauopathy by tau PET
• Detecting and Validating MAPT Mutations in Neurodegeneration Patients and Analysis of Exon Splicing Consequences
• Determinants of astrocytic pathology in stem cell models of primary tauopathies
• Differential Synaptic Loss in beta-Amyloid Positive Versus beta-Amyloid Negative Corticobasal Syndrome
• Disease-Associated Mutations in Tau Encode for Changes in Aggregate Structure Conformation
• Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies
• Distinct involvement of the cranial and spinal nerves in progressive supranuclear palsy
• Distinct tau folds initiate templated seeding and alter the post-translational modification profile
• Evaluating the efficacy of few-shot learning for GPT-4Vision in neurodegenerative disease histopathology: A comparative analysis with convolutional neural network model
• Fluid and tissue biomarkers in Parkinson's disease: Immunodetection or seed amplification? Central or peripheral?
• Gene specific effects on brain volume and cognition of TMEM106B in frontotemporal lobar degeneration
• Genetic and sporadic forms of tauopathies-TAU as a disease driver for the majority of patients but the minority of tauopathies
• Genetic forms of tauopathies: inherited causes and implications of Alzheimer's disease-like TAU pathology in primary and secondary tauopathies
• Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia
• Greater white matter degeneration and lower structural connectivity in non-amnestic vs. amnestic Alzheimer's disease
• Grey-matter correlates of empathy in 4-Repeat Tauopathies
• Huntingtin CAG repeats in neuropathologically confirmed tauopathies: Novel insights
• Hypertrophy of the inferior olivary nucleus in corticobasal degeneration: A neuropathological study
• Identification of metabolic pathways and key genes associated with atypical parkinsonism using a systems biology approach
• Impact of Magnetic Resonance Imaging Markers on the Diagnostic Performance of the International Parkinson and Movement Disorder Society Multiple System Atrophy Criteria
• In vitro evaluation of [³H]PI-2620 and structural derivatives in non-Alzheimer's tauopathies
• In vivo imaging of synaptic density in neurodegenerative disorders with positron emission tomography: A systematic review
• Interhemispheric reactivity of the subthalamic nucleus sustains progressive dopamine neuron loss in asymmetrical parkinsonism
• Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration
• Lateral geniculate body is spared of tau pathology in Pick disease
• Local structural preferences in shaping tau amyloid polymorphism
• Localizing apraxia in corticobasal syndrome: a morphometric MRI study
• Loss of Midbrain Dopamine Neurons Does Not Alter GABAergic Inhibition Mediated by Parvalbumin-Expressing Interneurons in Mouse Primary Motor Cortex
• MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study
• Meta-analysis of the association between <em>C9orf72</em> repeats and neurodegeneration diseases
• Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
• Midbrain atrophy in pathologically diagnosed Lewy body disease and clinically diagnosed Parkinson's disease
• Midbrain dopaminergic degeneration differentially modulates primary motor cortex activity and motor behavior in hemi-parkinsonian rats
• Monash-Alfred protocol for assessment of atypical parkinsonian syndromes (MAP-APS)
• Neurofilaments and progranulin are related to atrophy in frontotemporal lobar degeneration - A transdiagnostic study cross-validating atrophy and fluid biomarkers
• Neuroimaging-guided diagnosis of possible FTLD-FUS pathology: a case report
• Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism
• Neuropathological changes associated with aberrant cerebrospinal fluid p-tau181 and Aβ42 in Alzheimer's disease and other neurodegenerative diseases
• Neuropathology of the Neurodegenerative Diseases
• Novel Conformation-Dependent Tau Antibodies Are Modulated by Adjacent Phosphorylation Sites
• Nucleus Basalis of Meynert degeneration predicts cognitive decline in Corticobasal Syndrome
• Oligodendrocyte Dysfunction in Tauopathy: A Less Explored Area in Tau-Mediated Neurodegeneration
• Parkinson-ALS with a novel MAPT variant
• Pathology of neurodegenerative disease for the general neurologist
• PET imaging of synaptic density in Parkinsonian disorders
• Phenotypic and Positron Emission Tomography with [18F]fluordeoxyglucose (FDG PET) differences in corticobasal syndrome: comparison of two cases
• Pick's Disease Presenting as Tremulous Parkinsonism with Limited Levodopa Response-A Rare Cause of Corticobasal Syndrome
• Pick's disease presenting with corticobasal syndrome: A case report and clinicopathological review
• Polymerization of recombinant tau core fragments <em>in vitro</em> and seeding studies in cultured cells
• Potential dopaminergic deficit in patients with geriatric psychiatric disorders as revealed by DAT-SPECT: a cross-sectional study
• Probable 4-Repeat Tauopathy Criteria Predict Brain Amyloid Negativity, Distinct Clinical Features, and FDG-PET/MRI Neurodegeneneration Patterns in Corticobasal Syndrome
• Probe-dependent Proximity Profiling (ProPPr) Uncovers Similarities and Differences in Phospho-Tau-Associated Proteomes Between Tauopathies
• Progress in Primary Progressive Aphasia: A Review
• Progressive supranuclear palsy: A case report and brief review of the literature
• Proteomic networks of gray and white matter reveal tissue-specific changes in human tauopathy
• Relationships between PET and blood plasma biomarkers in corticobasal syndrome
• Reliability and Validity of Smartphone Cognitive Testing for Frontotemporal Lobar Degeneration
• Revisiting the relevance of Hirano bodies in neurodegenerative diseases
• Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception
• Seeding Activity of Skin Misfolded Tau as a Biomarker for Tauopathies
• Spatiotemporal characteristics of neurophysiological changes in patients with four-repeat tauopathies
• Subcortical tau is linked to hypoperfusion in connected cortical regions in 4-repeat tauopathies
• Synaptic changes in psychiatric and neurological disorders: state-of-the art of in vivo imaging
• Tau filaments from amyotrophic lateral sclerosis/parkinsonism-dementia complex adopt the CTE fold
• Tau in Atypical Parkinsonisms: A Meta-Analysis of in Vivo PET Imaging Findings
• Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies
• The enigma of depression in corticobasal degeneration, a frequent but poorly understood co-morbidity
• The Role of Dual-Phase 18 F-FP-CIT PET to Early Diagnosis of Corticobasal Syndrome
• The Role of Dual-Phase 18F-FP-CIT PET to Early Diagnosis of Corticobasal Syndrome
• The Role of MicroRNAs in Progressive Supranuclear Palsy-A Systematic Review
• The therapeutic landscape of tauopathies: challenges and prospects
• Total Patient Delay: A Comparison of Patient and Clinician/Health System Delays in the Diagnosis of Progressive Supranuclear Palsy and Corticobasal Syndrome
• Two distinct degenerative types of nigrostriatal dopaminergic neuron in the early stage of parkinsonian disorders
• Upper motor neuron-predominant motor neuron disease presenting as atypical parkinsonism: A clinicopathological study